Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 25, 2025 | (FY)Jul 26, 2025 | (Q4)Jul 26, 2025 | (Q3)Apr 26, 2025 | (Q2)Jan 25, 2025 | (Q1)Oct 26, 2024 | (FY)Jul 27, 2024 | (Q4)Jul 27, 2024 | (Q3)Apr 27, 2024 | (Q2)Jan 27, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.53%14.88B | 5.30%56.65B | 7.56%14.67B | 11.39%14.15B | 9.38%13.99B | -5.64%13.84B | -5.61%53.8B | -10.27%13.64B | -12.83%12.7B | -5.89%12.79B |
| Operating revenue | 7.53%14.88B | 5.30%56.65B | 7.56%14.67B | 11.39%14.15B | 9.38%13.99B | -5.64%13.84B | -5.61%53.8B | -10.27%13.64B | -12.83%12.7B | -5.89%12.79B |
| Cost of revenue | 8.86%5.14B | 4.69%19.86B | 10.94%5.39B | 9.98%4.87B | 6.69%4.88B | -7.65%4.72B | -10.68%18.98B | -10.89%4.86B | -17.04%4.43B | -11.44%4.57B |
| Gross profit | 6.84%9.75B | 5.63%36.79B | 5.68%9.28B | 12.15%9.28B | 10.88%9.11B | -4.56%9.12B | -2.59%34.83B | -9.92%8.78B | -10.39%8.27B | -2.49%8.22B |
| Operating expense | 2.25%6.24B | 11.11%24.29B | 1.77%6.16B | 9.06%6.04B | 17.20%5.99B | 18.22%6.1B | 8.26%21.86B | 14.34%6.05B | 6.56%5.54B | 4.44%5.11B |
| Selling and administrative expenses | 1.61%3.6B | 5.93%13.96B | -2.22%3.52B | 5.10%3.46B | 10.45%3.42B | 11.61%3.55B | 6.63%13.18B | 10.25%3.6B | 4.04%3.3B | 4.52%3.1B |
| -Selling and marketing expense | 4.32%2.87B | 5.81%10.97B | -0.81%2.82B | 6.45%2.72B | 8.71%2.67B | 9.82%2.75B | 4.90%10.36B | 10.16%2.84B | 1.31%2.56B | 3.10%2.46B |
| -General and administrative expense | -7.80%733M | 6.36%2.99B | -7.47%706M | 0.41%739M | 17.13%752M | 18.30%795M | 13.52%2.81B | 10.58%763M | 14.82%736M | 10.31%642M |
| Research and development costs | 4.99%2.4B | 16.50%9.3B | 9.22%2.38B | 19.87%2.34B | 18.32%2.3B | 19.50%2.29B | 5.72%7.98B | 11.57%2.18B | -0.71%1.95B | 4.74%1.94B |
| Depreciation amortization depletion | -12.83%231M | 47.28%1.03B | -5.22%254M | -17.85%244M | 301.52%265M | 295.52%265M | 147.52%698M | 282.86%268M | 324.29%297M | -7.04%66M |
| -Depreciation and amortization | -12.83%231M | 47.28%1.03B | -5.22%254M | -17.85%244M | 301.52%265M | 295.52%265M | 147.52%698M | 282.86%268M | 324.29%297M | -7.04%66M |
| Operating profit | 16.11%3.51B | -3.59%12.5B | 14.36%3.12B | 18.40%3.24B | 0.48%3.12B | -31.28%3.02B | -16.66%12.97B | -38.73%2.73B | -32.23%2.73B | -12.08%3.11B |
| Net non-operating interest income (expenses) | 3.03%-128M | -264.90%-592M | 4.73%-141M | -383.33%-153M | -181.37%-166M | -153.01%-132M | -32.90%359M | -173.63%-148M | -64.71%54M | 82.14%204M |
| Non-operating interest income | -22.38%222M | -26.67%1B | -15.93%227M | -39.17%250M | -26.54%238M | -20.56%286M | 41.89%1.37B | -13.46%270M | 56.87%411M | 47.95%324M |
| Non-operating interest expense | -16.27%350M | 58.35%1.59B | -11.96%368M | 12.89%403M | 236.67%404M | 276.58%418M | 135.60%1.01B | 276.58%418M | 227.52%357M | 12.15%120M |
| Other net income (expenses) | 101.44%9M | 25.84%-812M | 109.68%18M | 75.36%-136M | 53.64%-70M | -202.91%-624M | -40.56%-1.1B | 0.00%-186M | -141.05%-552M | 34.91%-151M |
| Gain on sale of security | 160.27%190M | 149.40%82M | 378.95%91M | -1,766.67%-56M | 76.58%-26M | 202.82%73M | 6.21%-166M | -53.66%19M | 97.76%-3M | -417.14%-111M |
| Special income (charges) | 77.89%-147M | 5.70%-744M | 68.75%-35M | 93.73%-34M | 16.67%-10M | -440.65%-665M | -48.59%-789M | 44.83%-112M | -522.99%-542M | 95.06%-12M |
| -Less:Restructuring and mergern&acquisition | -77.89%147M | -5.70%744M | -68.75%35M | -93.73%34M | -16.67%10M | 440.65%665M | 48.59%789M | -44.83%112M | 522.99%542M | -95.06%12M |
| Other non-operating income (expenses) | -6.25%-34M | -7.14%-150M | 59.14%-38M | -557.14%-46M | -21.43%-34M | -166.67%-32M | -97.18%-140M | -287.50%-93M | 12.50%-7M | -16.67%-28M |
| Income before tax | 49.58%3.39B | -9.27%11.1B | 25.17%3B | 31.86%2.95B | -8.67%2.89B | -48.96%2.27B | -20.13%12.23B | -46.41%2.4B | -43.52%2.24B | -7.44%3.16B |
| Income tax | 219.59%531M | -51.93%920M | 91.88%449M | 30.66%456M | -12.90%459M | -155.22%-444M | -29.24%1.91B | -54.39%234M | -53.15%349M | -17.91%527M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 5.50%2.86B | -1.36%10.18B | 17.95%2.55B | 32.08%2.49B | -7.82%2.43B | -25.48%2.71B | -18.18%10.32B | -45.38%2.16B | -41.28%1.89B | -5.01%2.63B |
| Net income continuous operations | 5.50%2.86B | -1.36%10.18B | 17.95%2.55B | 32.08%2.49B | -7.82%2.43B | -25.48%2.71B | -18.18%10.32B | -45.38%2.16B | -41.28%1.89B | -5.01%2.63B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 5.50%2.86B | -1.36%10.18B | 17.95%2.55B | 32.08%2.49B | -7.82%2.43B | -25.48%2.71B | -18.18%10.32B | -45.38%2.16B | -41.28%1.89B | -5.01%2.63B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 5.50%2.86B | -1.36%10.18B | 17.95%2.55B | 32.08%2.49B | -7.82%2.43B | -25.48%2.71B | -18.18%10.32B | -45.38%2.16B | -41.28%1.89B | -5.01%2.63B |
| Diluted earnings per share | 5.88%0.2459 | 0.39%0.8741 | 31.48%0.2424 | 34.04%0.2151 | -6.15%0.2083 | -24.44%0.2322 | -17.21%0.8707 | -44.33%0.1844 | -40.51%0.1605 | -4.41%0.2219 |
| Basic earnings per share | 5.88%0.2459 | 0.39%0.8707 | 31.48%0.2424 | 34.78%0.2117 | -6.15%0.2083 | -23.60%0.2322 | -17.26%0.8673 | -44.33%0.1844 | -41.03%0.1571 | -2.99%0.2219 |
| Dividend per share | -4.52%0.1438 | -74.99%0.1469 | 0.62%0.1469 | -8.13%0.1364 | -6.63%0.1381 | 3.98%0.1506 | 1.42%0.5872 | -2.03%0.146 | 0.51%0.1484 | 5.81%0.1479 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.